Edition:
United States

Threshold Pharmaceuticals Inc (THLD.OQ)

THLD.OQ on NASDAQ Stock Exchange Capital Market

0.62USD
27 Feb 2017
Change (% chg)

$0.01 (+1.86%)
Prev Close
$0.61
Open
$0.58
Day's High
$0.64
Day's Low
$0.58
Volume
52,875
Avg. Vol
129,565
52-wk High
$1.48
52-wk Low
$0.22

THLD.OQ

Chart for THLD.OQ

About

Threshold Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. It is developing two therapeutic product candidates based on hypoxia-activat... (more)

Overall

Beta: 3.11
Market Cap(Mil.): $43.24
Shares Outstanding(Mil.): 71.56
Dividend: --
Yield (%): --

Financials

  THLD.OQ Industry Sector
P/E (TTM): 1.12 44.08 29.63
EPS (TTM): 0.54 -- --
ROI: 150.13 -3.35 12.96
ROE: -- 5.80 14.11

BRIEF-First Eagle Investment Management LLC reports 9.91 pct passive stake in Threshold Pharmaceuticals

* First Eagle Investment Management LLC reports a 9.91 percent passive stake in Threshold Pharmaceuticals Inc as on December 31, 2016 - SEC filing Source text (http://bit.ly/2kkln0x) Further company coverage:

Feb 06 2017

BRIEF-Threshold Pharmaceuticals qtrly loss per share $0.08

* Threshold pharmaceuticals reports third quarter financial results

Nov 07 2016

BRIEF-Threshold Pharmaceuticals Qtrly loss per share $0.08

* No revenue was recognized in Q3 ended September 30, 2016 compared to $3.7 million for same period of 2015

Nov 07 2016

More From Around the Web

Earnings vs. Estimates